These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9756518)

  • 1. Localization and secretion of tissue kallikrein in peptidoglycan-induced enterocolitis in Lewis rats.
    Stadnicki A; Chao J; Stadnicka I; Van Tol E; Lin KF; Li F; Sartor RB; Colman RW
    Am J Physiol; 1998 Oct; 275(4):G854-61. PubMed ID: 9756518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats.
    McCall RD; Haskill S; Zimmermann EM; Lund PK; Thompson RC; Sartor RB
    Gastroenterology; 1994 Apr; 106(4):960-72. PubMed ID: 8144001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and tissue kallikrein in arthritis and inflammatory bowel disease.
    Colman RW
    Immunopharmacology; 1999 Sep; 43(2-3):103-8. PubMed ID: 10596840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the kallikrein-kinin system in arthritis and enterocolitis in genetically susceptible rats: modulation by a selective plasma kallikrein inhibitor.
    Colman RW; Stadnicki A; Kettner CA; Adam AA; DeLa Cadena RA; Sartor RB
    Proc Assoc Am Physicians; 1997 Jan; 109(1):10-22. PubMed ID: 9010912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kininogen deficiency modulates chronic intestinal inflammation in genetically susceptible rats.
    Isordia-Salas I; Pixley RA; Li F; Sainz I; Sartor RB; Adam A; Colman RW
    Am J Physiol Gastrointest Liver Physiol; 2002 Jul; 283(1):G180-6. PubMed ID: 12065305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone reduces the severity of fibrosis associated with chronic intestinal inflammation.
    Theiss AL; Fuller CR; Simmons JG; Liu B; Sartor RB; Lund PK
    Gastroenterology; 2005 Jul; 129(1):204-19. PubMed ID: 16012948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective plasma kallikrein inhibitor attenuates acute intestinal inflammation in Lewis rat.
    Stadnicki A; DeLa Cadena RA; Sartor RB; Bender D; Kettner CA; Rath HC; Adam A; Colman RW
    Dig Dis Sci; 1996 May; 41(5):912-20. PubMed ID: 8625762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective kallikrein-kinin system activation in inbred rats differentially susceptible to granulomatous enterocolitis.
    Sartor RB; DeLa Cadena RA; Green KD; Stadnicki A; Davis SW; Schwab JH; Adam AA; Raymond P; Colman RW
    Gastroenterology; 1996 May; 110(5):1467-81. PubMed ID: 8613052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific inhibition of plasma kallikrein modulates chronic granulomatous intestinal and systemic inflammation in genetically susceptible rats.
    Stadnicki A; Sartor RB; Janardham R; Majluf-Cruz A; Kettner CA; Adam AA; Colman RW
    FASEB J; 1998 Mar; 12(3):325-33. PubMed ID: 9506476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kallikrein-kininogen system activation and bradykinin (B2) receptors in indomethacin induced enterocolitis in genetically susceptible Lewis rats.
    Stadnicki A; Sartor RB; Janardham R; Stadnicka I; Adam AA; Blais C; Colman RW
    Gut; 1998 Sep; 43(3):365-74. PubMed ID: 9863482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial cell wall polymers promote intestinal fibrosis by direct stimulation of myofibroblasts.
    van Tol EA; Holt L; Li FL; Kong FM; Rippe R; Yamauchi M; Pucilowska J; Lund PK; Sartor RB
    Am J Physiol; 1999 Jul; 277(1):G245-55. PubMed ID: 10409173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of kallikrein-kinin system in pathogenesis of bacterial cell wall-induced inflammation.
    DeLa Cadena RA; Laskin KJ; Pixley RA; Sartor RB; Schwab JH; Back N; Bedi GS; Fisher RS; Colman RW
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G213-9. PubMed ID: 1996642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic intestinal inflammation and angiogenesis in genetically susceptible rats is modulated by kininogen deficiency.
    Isordia-Salas I; Pixley RA; Li F; Sainz I; Balfour Sartor R; Adam A; Colman RW
    Int Immunopharmacol; 2002 Dec; 2(13-14):1895-905. PubMed ID: 12489803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of plasma high molecular weight kininogen in experimental intestinal and systemic inflammation.
    Isordia-Salas I; Pixley RA; Sáinz IM; Martínez-Murillo C; Colman RW
    Arch Med Res; 2004; 35(5):369-77. PubMed ID: 15610905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal tissue kallikrein-kallistatin profile in inflammatory bowel disease.
    Stadnicki A; Mazurek U; Plewka D; Wilczok T
    Int Immunopharmacol; 2003 Jul; 3(7):939-44. PubMed ID: 12810351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulinlike growth factor I and interleukin 1 beta messenger RNA in a rat model of granulomatous enterocolitis and hepatitis.
    Zimmermann EM; Sartor RB; McCall RD; Pardo M; Bender D; Lund PK
    Gastroenterology; 1993 Aug; 105(2):399-409. PubMed ID: 8335195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of group A streptococcal peptidoglycan-polysaccharide (PG-APS)-stimulated macrophage production of IL-1 by rat strains susceptible and resistant to PG-APS-induced arthritis.
    Bristol LA; Durum SK; Eisenberg SP
    Cell Immunol; 1993 Jun; 149(1):130-43. PubMed ID: 8513508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal tissue kallikrein-kinin system in inflammatory bowel disease.
    Stadnicki A
    Inflamm Bowel Dis; 2011 Feb; 17(2):645-54. PubMed ID: 20848521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of plasma kallikrein prevents peptidoglycan-induced arthritis in the Lewis rat.
    Dela Cadena RA; Stadnicki A; Uknis AB; Sartor RB; Kettner CA; Adam A; Colman RW
    FASEB J; 1995 Mar; 9(5):446-52. PubMed ID: 7896018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contact system in experimental enterocolitis.
    Stadnicki A; DeLa Cadena RA; Sartor RB; Kettner CA; Colman RW
    Immunopharmacology; 1996 Jun; 33(1-3):314-6. PubMed ID: 8856173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.